{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:06Z","timestamp":1787020806681,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Patients with systemic lupus erythematosus (SLE) are at higher risk for osteoporosis and fragility fractures. Our study aimed to identify disease-specific factors with impact on bone mineral density (BMD) and the risk of osteoporosis, and to evaluate the effectiveness of DXA-derived 3D femur parameters versus BMD and trabecular bone score (TBS) in discriminating pre-existent fragility fractures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed baseline data of a consecutive subcohort of patients with SLE with current or past GC treatment, fulfilling the EULAR\/ACR 2019 SLE classification criteria. We used multivariable linear and logistic regression models to identify BMD- and osteoporosis-related factors. DXA-derived 3D measurements of the femur were performed with 3D-Shaper software. Discriminatory performance of BMD, TBS and 3D femoral parameters for fragility fractures was assessed by AUC values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-one percent of 110 patients with SLE had osteoporosis. Lupus nephritis (LN) was present in 35% of cases, with 61% (23\/38) of these being predominantly classified as classes IV and V. Factors significantly associated with lower BMD included LN classes III and IV, U1-RNP antibodies, higher C-reactive protein, and longer disease duration. Clinical remission, higher Siglec-1 levels, higher body mass index, and higher health assessment questionnaire (HAQ) scores correlated positively with BMD. Osteoporosis was linked to LN, higher age, HAQ, and complement factor 3 levels. Our findings suggest that 3D bone structure analysis may be helpful in discriminating past vertebral fractures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Disease severity indicated by LN, high CRP, presence of U1-RNP antibodies, and extended disease duration are detrimental to bone health. Moreover, 3D-DXA parameters can be integrated in clinical practise to assess bone health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-025-03610-y","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:45:27Z","timestamp":1753706727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lupus nephritis and U1-RNP-antibodies are associated with low bone mineral density and osteoporosis in patients with systemic lupus erythematosus: baseline findings in a sub-cohort of patients with inflammatory rheumatic diseases"],"prefix":"10.1186","volume":"27","author":[{"given":"Edgar","family":"Wiebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Celine","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6rte","family":"Huscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriko","family":"Palmowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhivana","family":"Boyadzhieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Muche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella Lopez","family":"Picazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Kr\u00f6nke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Hiepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Buttgereit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"4","key":"3610_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00198-015-3449-7","volume":"27","author":"X Wang","year":"2016","unstructured":"Wang X, Yan S, Liu C, Xu Y, Wan L, Wang Y, Gao W, Meng S, Liu Y, Liu R, et al. Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int. 2016;27(4):1413\u201323.","journal-title":"Osteoporos Int"},{"issue":"7","key":"3610_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/art.40818","volume":"71","author":"SK Tedeschi","year":"2019","unstructured":"Tedeschi SK, Kim SC, Guan H, Grossman JM, Costenbader KH. Comparative fracture risks among united states medicaid enrollees with and those without systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(7):1141\u20136.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3610_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000098","volume":"3","author":"L Carli","year":"2016","unstructured":"Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, Di Munno O, Mosca M. Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med. 2016;3(1): e000098.","journal-title":"Lupus Sci Med"},{"issue":"4","key":"3610_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0961203316664597","volume":"26","author":"G Cramarossa","year":"2017","unstructured":"Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus. Lupus. 2017;26(4):365\u201372.","journal-title":"Lupus"},{"issue":"1","key":"3610_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0961203317709953","volume":"27","author":"B Le","year":"2018","unstructured":"Le B, Waller JL, Radhakrishnan R, Oh SJ, Kheda MF, Nahman NS Jr, Carbone L. Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease. Lupus. 2018;27(1):17\u201324.","journal-title":"Lupus"},{"issue":"1","key":"3610_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-019-0667-1","volume":"15","author":"C Gu","year":"2019","unstructured":"Gu C, Zhao R, Zhang X, Gu Z, Zhou W, Wang Y, Guo J, Bao Y, Sun C, Dong C, et al. A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors. Arch Osteoporos. 2019;15(1):1.","journal-title":"Arch Osteoporos"},{"issue":"4","key":"3610_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/BOR.0000000000000290","volume":"28","author":"IEM Bultink","year":"2016","unstructured":"Bultink IEM, Lems WF. Lupus and fractures. Curr Opin Rheumatol. 2016;28(4):426\u201332.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"3610_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/rheumatology\/kex444","volume":"57","author":"J Little","year":"2018","unstructured":"Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, et al. Glucocorticoid use and factors associated with variability in this use in the systemic lupus international collaborating clinics inception cohort. Rheumatology (Oxford). 2018;57(4):677\u201387.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"3610_CR9","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","volume":"18","author":"KL Stone","year":"2003","unstructured":"Stone KL, Seeley DG, Lui L-Y, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res. 2003;18(11):1947\u201354.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3610_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1210\/jc.2014-3777","volume":"100","author":"WD Leslie","year":"2015","unstructured":"Leslie WD, Majumdar SR, Morin SN, Lix LM. Why does rate of bone density loss not predict fracture risk? J Clin Endocrinol Metab. 2015;100(2):679\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"3610_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-018-0062-7","volume":"4","author":"P Choksi","year":"2018","unstructured":"Choksi P, Jepsen KJ, Clines GA. The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin Diabetes Endocrinol. 2018;4:12.","journal-title":"Clin Diabetes Endocrinol"},{"key":"3610_CR12","doi-asserted-by":"crossref","unstructured":"Mendoza-Pinto C, Rojas-Villarraga A, Molano-Gonz\u00e1lez N, Jim\u00e9nez-Herrera EA, Le\u00f3n-V\u00e1zquez MdlL, Montiel-Jarqu\u00edn \u00c1, Garc\u00eda-Carrasco M, Cervera R: Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression. PLOS ONE 2018, 13(6):e0196113.","DOI":"10.1371\/journal.pone.0196113"},{"issue":"5","key":"3610_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00198-015-3461-y","volume":"27","author":"JA Paupitz","year":"2016","unstructured":"Paupitz JA, Lima GL, Alvarenga JC, Oliveira RM, Bonfa E, Pereira RMR. Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus. Osteoporos Int. 2016;27(5):1839\u201348.","journal-title":"Osteoporos Int"},{"key":"3610_CR14","doi-asserted-by":"publisher","first-page":"1111020","DOI":"10.3389\/fbioe.2023.1111020","volume":"11","author":"A Dudle","year":"2023","unstructured":"Dudle A, Gugler Y, Pretterklieber M, Ferrari S, Lippuner K, Zysset P. 2D\u20133D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software. Front Bioeng Biotechnol. 2023;11:1111020.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"3610_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/annrheumdis-2022-222339","volume":"81","author":"E Wiebe","year":"2022","unstructured":"Wiebe E, Huscher D, Schaumburg D, Palmowski A, Hermann S, Buttgereit T, Biesen R, Burmester GR, Palmowski Y, Boers M, et al. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis. 2022;81(9):1313\u201322.","journal-title":"Ann Rheum Dis"},{"key":"3610_CR16","unstructured":"Dachverband Osteologie (DVO) e.V. Leitlinie des Dachverbandes Osteologie zur Prophylaxe, Diagnostik und Therapie der Osteoporose \u2013 S3-Leitlinie. Version\u202f2.1, 10. September\u202f2023. Essen: Dachverband Osteologie; 2023. https:\/\/leitlinien.dv-osteologie.org."},{"issue":"2","key":"3610_CR17","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"9","key":"3610_CR18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","volume":"75","author":"K Franklyn","year":"2016","unstructured":"Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, et al. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis. 2016;75(9):1615\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3610_CR19","doi-asserted-by":"publisher","first-page":"e000538","DOI":"10.1136\/lupus-2021-000538","volume":"8","author":"RF van Vollenhoven","year":"2021","unstructured":"van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A et al: 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 2021, 8(1):e000538.","journal-title":"Lupus Sci Med"},{"key":"3610_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","volume":"78","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Gl\u00fcer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C, Kendler D, Lamy O, Laslop A, Camargos BM, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216\u201324.","journal-title":"Bone"},{"issue":"1","key":"3610_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11657-020-00726-3","volume":"15","author":"EL Lai","year":"2020","unstructured":"Lai EL, Huang WN, Chen HH, Chen JP, Chen DY, Hsieh TY, Hung WT, Lai KL, Lin CT, Tang KT, et al. Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosus. Arch Osteoporos. 2020;15(1):54.","journal-title":"Arch Osteoporos"},{"issue":"1","key":"3610_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1109\/TMI.2016.2593346","volume":"36","author":"L Humbert","year":"2017","unstructured":"Humbert L, Martelli Y, Fonolla R, Steghofer M, Di Gregorio S, Malouf J, Romera J, Barquero LM. 3D-DXA: Assessing the Femoral Shape, the Trabecular Macrostructure and the Cortex in 3D from DXA images. IEEE Trans Med Imaging. 2017;36(1):27\u201339.","journal-title":"IEEE Trans Med Imaging"},{"key":"3610_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmed.2024.1341077","volume":"11","author":"E Toussirot","year":"2024","unstructured":"Toussirot E, Winzenrieth R, Aubin F, Wendling D, Vauchy C, Desmarets M. Areal bone mineral density, trabecular bone score and 3D-DXA analysis of proximal femur in psoriatic disease. Frontiers in Medicine. 2024;11:11.","journal-title":"Frontiers in Medicine"},{"issue":"3","key":"3610_CR24","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/rheumatology\/keae142","volume":"64","author":"C Midol","year":"2024","unstructured":"Midol C, Wiebe E, Siegert E, Huscher D, B\u00e9hal H, Launay D, Hachulla E, Matteson EL, Buttgereit F, Sobanski V. Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis. Rheumatology (Oxford). 2024;64(3):1270\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3610_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","volume":"76","author":"R van Vollenhoven","year":"2017","unstructured":"van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Bal\u00e1\u017eov\u00e1 P, Bonfa E, Bootsma H, et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2017;76(3):554\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3610_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5606\/ArchRheumatol.2017.6127","volume":"33","author":"H Wang","year":"2018","unstructured":"Wang H, Ren YL, Chang J, Gu L, Sun LY. A systematic review and meta-analysis of prevalence of biopsy-proven lupus nephritis. Arch Rheumatol. 2018;33(1):17\u201325.","journal-title":"Arch Rheumatol"},{"issue":"5","key":"3610_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.autrev.2012.12.001","volume":"12","author":"RK Luijten","year":"2013","unstructured":"Luijten RK, Fritsch-Stork RD, Bijlsma JW, Derksen RH. The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science. Autoimmun Rev. 2013;12(5):617\u201328.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"3610_CR28","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/art.34474","volume":"64","author":"P de Pablo","year":"2012","unstructured":"de Pablo P, Cooper MS, Buckley CD. Association between bone mineral density and C-reactive protein in a large population-based sample. Arthritis Rheum. 2012;64(8):2624\u201331.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3610_CR29","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1210\/jc.2007-2325","volume":"93","author":"C Ding","year":"2008","unstructured":"Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93(5):1952\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3610_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","volume":"16","author":"JM Koh","year":"2005","unstructured":"Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005;16(10):1263\u201371.","journal-title":"Osteoporos Int"},{"issue":"10","key":"3610_CR31","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1136\/annrheumdis-2012-201586","volume":"72","author":"T Rose","year":"2013","unstructured":"Rose T, Gr\u00fctzkau A, Hirseland H, Huscher D, D\u00e4hnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, et al. IFN\u03b1 and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 2013;72(10):1639\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"6882","key":"3610_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature. 2002;416(6882):744\u20139.","journal-title":"Nature"},{"issue":"1","key":"3610_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajpath.2012.03.023","volume":"181","author":"M Wilkison","year":"2012","unstructured":"Wilkison M, Gauss K, Ran Y, Searles S, Taylor D, Meissner N. Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. Am J Pathol. 2012;181(1):151\u201362.","journal-title":"Am J Pathol"},{"issue":"1","key":"3610_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.0105-2896.2005.00337.x","volume":"208","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi H, Sato K, Takaoka A, Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev. 2005;208(1):181\u201393.","journal-title":"Immunol Rev"},{"issue":"7","key":"3610_CR35","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","volume":"38","author":"A Dima","year":"2018","unstructured":"Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38(7):1169\u201378.","journal-title":"Rheumatol Int"},{"issue":"6","key":"3610_CR36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00223-014-9918-8","volume":"95","author":"S Hansen","year":"2014","unstructured":"Hansen S, Gudex C, \u00c5hrberg F, Brixen K, Voss A. Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT. Calcif Tissue Int. 2014;95(6):530\u20139.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"3610_CR37","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00198-012-2177-5","volume":"24","author":"XL Tang","year":"2013","unstructured":"Tang XL, Qin L, Kwok AW, Zhu TY, Kun EW, Hung VW, Griffith JF, Leung PC, Li EK, Tam LS. Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT. Osteoporos Int. 2013;24(6):1817\u201326.","journal-title":"Osteoporos Int"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03610-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:13:29Z","timestamp":1757304809000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03610-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03610-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved human participants. Ethical and regulatory authorizations were obtained local ethics committee of Charit\u00e9-Universit\u00e4tsmedizin Berlin ethical committee (EA1\/367\/14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}